{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:45:57Z","timestamp":1788417957365,"version":"build-2803163510"},"reference-count":65,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Etiologic heterogeneity in breast carcinogenesis needs to be well characterized for targeted prevention. Associations between menopausal hormonal therapy (MHT) and oral contraceptive (OC) use and breast cancer intrinsic-like subtypes are not well understood.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine whether exogenous hormone use is differentially associated with breast cancer subtypes and to evaluate heterogeneity by intrinsic-like subtypes.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This study pooled data from 31 nested and population-based case-control studies involved in the Breast Cancer Association Consortium. The study population included individuals with breast cancer and control participants from 13 case-control studies nested in prospective cohorts (recruited between 1982 and 2011) and 18 population-based case-control studies (recruited between 1990 and 2013). Data analysis was performed in June 2024.<\/jats:p><\/jats:sec>Exposure<\/jats:title>MHT use (estrogen-progestin therapy [EPT] or estrogen-only therapy [ET]) in postmenopausal women and OC use in premenopausal women (never, past use, or current use).<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Breast cancer intrinsic-like subtypes (luminal A\u2013like, luminal B\u2013like, luminal B\u2013ERBB2 [formerly HER2 or HER2\/neu]-like, ERBB2 enriched\u2013like, or triple-negative) were determined by immunohistochemistry of tumor sections. Polytomous logistic regression was performed to estimate the association between exogenous hormones and risk of breast cancer by intrinsic-like subtypes. Analyses by subtypes were stratified by body mass index (BMI [calculated as weight in kilograms divided by height in meters squared]; healthy weight, 18.5-&amp;lt;25; overweight, 25-&amp;lt;30; or obesity, \u226530).<\/jats:p><\/jats:sec>Results<\/jats:title>This study included 42\u202f269 individuals with breast cancer (11\u202f901 [28.2%] premenopausal and 30\u202f368 [71.8%] postmenopausal; 23\u202f353 [55.2%] had a known intrinsic-like subtype) and 71\u202f072 control participants. The mean (SD) age of all participants was 57.9 (10.9) years. In postmenopausal women, associations between current MHT use (EPT or ET) and breast cancer differed by subtype. Current EPT users with healthy weight were more likely to be diagnosed with luminal A\u2013like (odds ratio [OR], 2.51 [95% CI, 2.26-2.80]) or luminal B\u2013ERBB2-like (OR, 1.95 [95% CI, 1.61-2.37]) subtypes. These associations were attenuated but remained for individuals with overweight (OR, 1.40 [95% CI, 1.02-1.92]) or obesity (OR, 1.68 [95% CI, 1.01-2.78]). EPT use increased the odds of being diagnosed with luminal B\u2013like tumors solely in women with healthy weight (OR, 1.47 [95% CI, 1.17-1.86]). Current ET use was positively associated with luminal A\u2013like disease in women with healthy weight only (OR, 1.16 [95% CI, 1.01-1.32]), showing inverse associations with higher BMI (obesity: OR, 0.65 [95% CI, 0.50-0.85]). In premenopausal women, recent OC use was associated with luminal B\u2013ERBB2-like (OR, 1.50 [95% CI, 1.09-2.08]), ERBB2 enriched\u2013like (OR, 2.33 [95% CI, 1.55-3.51]), and triple-negative (OR, 1.75 [95% CI, 1.33-2.29]; P<\/jats:italic>\u2009&amp;lt;\u2009.04 for heterogeneity) tumors.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this study, clear differences were observed in associations between current EPT use and luminal-like breast cancer subtypes and other subtypes. EPT users with healthy weight were more likely to be diagnosed with luminal-like breast cancer compared with nonusers. Subtype heterogeneity was less apparent in associations of OC and ET use. Future studies on contemporary formulations, patterns of use, and routes of administration of exogenous hormone usage are warranted.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.19236","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T15:00:45Z","timestamp":1751900445000},"page":"e2519236","source":"Crossref","is-referenced-by-count":9,"title":["Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer"],"prefix":"10.1001","volume":"8","author":[{"given":"Charlotte","family":"Le Cornet","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey Y.","family":"Jung","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Behrens","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Middha","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany"},{"name":"Division of General Internal Medicine, Department of Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Truong","sequence":"additional","affiliation":[{"name":"Paris-Saclay University, Universit\u00e9 de Versailles Saint-Quentin-en-Yvelines, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Gustave Roussy, Centre for Epidemiology and Population Health, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Jernstr\u00f6m","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjeet K.","family":"Bolla","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Southey","sequence":"additional","affiliation":[{"name":"Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia"},{"name":"Department of Clinical Pathology, University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Beane Freeman","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Koutros","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Stone","sequence":"additional","affiliation":[{"name":"Genetic Epidemiology Group, School of Population and Global Health, University of Western Australia, Perth, Western Australia, Australia"},{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Rennert","sequence":"additional","affiliation":[{"name":"Technion-Israel Institute of Technology\u2013Association for Promotion of Research in Precision Medicine, Faculty of Medicine, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Shulman","sequence":"additional","affiliation":[{"name":"Oncology Department, Clalit Health Services, Haifa and Western Galilee District, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristan J.","family":"Aronson","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Cancer Research Institute, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Murphy","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Gu\u00e9nel","sequence":"additional","affiliation":[{"name":"Paris-Saclay University, Universit\u00e9 de Versailles Saint-Quentin-en-Yvelines, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Gustave Roussy, Centre for Epidemiology and Population Health, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpa V.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Population Science, American Cancer Society, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Bodelon","sequence":"additional","affiliation":[{"name":"Department of Population Science, American Cancer Society, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren R.","family":"Teras","sequence":"additional","affiliation":[{"name":"Department of Population Science, American Cancer Society, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamim","family":"Shahi","sequence":"additional","affiliation":[{"name":"Department of Population Science, American Cancer Society, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James V.","family":"Lacey","sequence":"additional","affiliation":[{"name":"Department of Computational and Quantitative Medicine, City of Hope, Duarte, California"},{"name":"City of Hope Comprehensive Cancer Center, City of Hope, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Dossus","sequence":"additional","affiliation":[{"name":"Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Kaaks","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Holleczek","sequence":"additional","affiliation":[{"name":"Saarland Cancer Registry, Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Brenner","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany"},{"name":"German Cancer Research Center, German Cancer Consortium, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiltrud","family":"Brauch","sequence":"additional","affiliation":[{"name":"Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany"},{"name":"iFIT (Image-Guided and Functionally Instructed Tumor Therapies) Cluster of Excellence, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"German Cancer Consortium and German Cancer Research Center Partner Site T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Hoppe","sequence":"additional","affiliation":[{"name":"Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany"},{"name":"University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Czene","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Frans Leonard","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Oncology, S\u00f6dersjukhuset, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto","family":"Mannermaa","sequence":"additional","affiliation":[{"name":"Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland"},{"name":"Pathology and Forensic Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland"},{"name":"Biobank of Eastern Finland, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna H.","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Population Health and Public Health Sciences, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Obi","sequence":"additional","affiliation":[{"name":"Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriaki","family":"Michailidou","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom"},{"name":"Biostatistics Unit, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihalis I.","family":"Panayiotidis","sequence":"additional","affiliation":[{"name":"Department of Cancer Genetics, Therapeutics, and Ultrastructural Pathology, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus"},{"name":"Now with Department of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Starkville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"McLean","sequence":"additional","affiliation":[{"name":"Anatomical Pathology Unit, Alfred Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Haiman","sequence":"additional","affiliation":[{"name":"Department of Population and Public Health Sciences, Center for Genetic Epidemiology, Keck School of Medicine, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelie","family":"Augustinsson","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ou","family":"Shu","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Perou","sequence":"additional","affiliation":[{"name":"Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Troester","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Gillings School of Global Public Health, UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Van Alsten","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Gillings School of Global Public Health, UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Heather","family":"Eliassen","sequence":"additional","affiliation":[{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Abubakar","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kraft","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas U.","family":"Ahearn","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Gareth","family":"Evans","sequence":"additional","affiliation":[{"name":"Division of Evolution and Genomic Sciences, Faculty of Biology, Medicine, and Health, Manchester Academic Health Science Centre, School of Biological Sciences, University of Manchester, Manchester, United Kingdom"},{"name":"North West Genomics Laboratory Hub, St Mary\u2019s Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester Centre for Genomic Medicine, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Wolk","sequence":"additional","affiliation":[{"name":"Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Milne","sequence":"additional","affiliation":[{"name":"Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia"},{"name":"Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia"},{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas F.","family":"Easton","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom"},{"name":"Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D. P.","family":"Pharoah","sequence":"additional","affiliation":[{"name":"Department of Computational Biomedicine, Cedars-Sinai Medical Center, West Hollywood, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjanka K.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Division of Molecular Pathology, Netherlands Cancer Institute\u2013Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands"},{"name":"Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute\u2013Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands"},{"name":"Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Garc\u00eda-Closas","sequence":"additional","affiliation":[{"name":"Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine M.","family":"Vachon","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e T.","family":"Fortner","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany"},{"name":"Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Chang-Claude","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany"},{"name":"Cancer Epidemiology Group, University Medical Center Hamburg-Eppendorf, University Cancer Center Hamburg, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"issue":"10204","key":"zoi250598r1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.","volume":"394","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"zoi250598r2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41416-024-02590-1","article-title":"Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway.","volume":"131","author":"St\u00f8er","year":"2024","journal-title":"Br J Cancer"},{"issue":"4","key":"zoi250598r3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/jama.2020.9482","article-title":"Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the Women\u2019s Health Initiative randomized clinical trials.","volume":"324","author":"Chlebowski","year":"2020","journal-title":"JAMA"},{"issue":"11","key":"zoi250598r4","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.3390\/cancers13112710","article-title":"Is breast cancer risk associated with menopausal hormone therapy modified by current or early adulthood BMI or age of first pregnancy?","volume":"13","author":"Leventea","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"46","key":"zoi250598r5","doi-asserted-by":"publisher","first-page":"81109","DOI":"10.18632\/oncotarget.20154","article-title":"Change in risk of breast cancer after receiving hormone replacement therapy by considering effect-modifiers: a systematic review and dose-response meta-analysis of prospective studies.","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"zoi250598r6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13058-020-01365-9","article-title":"Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.","volume":"22","author":"Wang","year":"2020","journal-title":"Breast Cancer Res"},{"issue":"3","key":"zoi250598r7","doi-asserted-by":"publisher","first-page":"R76","DOI":"10.1186\/bcr3186","article-title":"Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.","volume":"14","author":"Ritte","year":"2012","journal-title":"Breast Cancer Res"},{"issue":"1","key":"zoi250598r8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13058-016-0798-x","article-title":"Parity, hormones and breast cancer subtypes: results from a large nested case-control study in a national screening program.","volume":"19","author":"Ellingjord-Dale","year":"2017","journal-title":"Breast Cancer Res"},{"issue":"6","key":"zoi250598r9","doi-asserted-by":"publisher","first-page":"821.e1","DOI":"10.1016\/j.ajog.2021.12.022","article-title":"Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses\u2019 Health Study II: a prospective cohort study.","volume":"226","author":"Burchardt","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"9017","key":"zoi250598r10","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","journal-title":"Lancet"},{"issue":"23","key":"zoi250598r11","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer.","volume":"377","author":"M\u00f8rch","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi250598r12","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1158\/1055-9965.EPI-10-0428","article-title":"Oral contraceptive use and estrogen\/progesterone receptor-negative breast cancer among African American women.","volume":"19","author":"Rosenberg","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"zoi250598r13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13058-015-0535-x","article-title":"A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium.","volume":"17","author":"Bethea","year":"2015","journal-title":"Breast Cancer Res"},{"issue":"5","key":"zoi250598r14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1158\/1055-9965.EPI-13-0944","article-title":"Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.","volume":"23","author":"Beaber","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"zoi250598r15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/1471-2407-13-584","article-title":"Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.","volume":"13","author":"Ritte","year":"2013","journal-title":"BMC Cancer"},{"issue":"20","key":"zoi250598r16","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1158\/0008-5472.CAN-18-0502","article-title":"Pooled analysis of nine cohorts reveals breast cancer risk factors by tumor molecular subtype.","volume":"78","author":"Gaudet","year":"2018","journal-title":"Cancer Res"},{"issue":"12","key":"zoi250598r17","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1093\/jnci\/djac117","article-title":"Distinct reproductive risk profiles for intrinsic-like breast cancer subtypes: pooled analysis of population-based studies.","volume":"114","author":"Jung","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"16","key":"zoi250598r18","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1093\/hmg\/ddr228","article-title":"Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.","volume":"20","author":"Broeks","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"1","key":"zoi250598r19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/ije\/dyz193","article-title":"Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium.","volume":"49","author":"Kapoor","year":"2020","journal-title":"Int J Epidemiol"},{"issue":"5","key":"zoi250598r20","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/sim.6793","article-title":"Statistical methods for studying disease subtype heterogeneity.","volume":"35","author":"Wang","year":"2016","journal-title":"Stat Med"},{"issue":"5","key":"zoi250598r21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/jama.1996.03530290040035","article-title":"Effects of hormone replacement therapy on endometrial histology in postmenopausal women: the Postmenopausal Estrogen\/Progestin Interventions (PEPI) trial.","volume":"275","author":"The Writing Group for the PEPI Trial","year":"1996","journal-title":"JAMA"},{"issue":"3","key":"zoi250598r22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"11","key":"zoi250598r23","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/JOM.0b013e3181f72b7c","article-title":"An update of cancer incidence in the Agricultural Health Study.","volume":"52","author":"Koutros","year":"2010","journal-title":"J Occup Environ Med"},{"issue":"9","key":"zoi250598r24","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1002\/cncr.101970","article-title":"The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics.","volume":"94","author":"Calle","year":"2002","journal-title":"Cancer"},{"issue":"7","key":"zoi250598r25","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1023\/A:1019552126105","article-title":"High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States).","volume":"13","author":"Bernstein","year":"2002","journal-title":"Cancer Causes Control"},{"issue":"6B","key":"zoi250598r26","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1079\/PHN2002394","article-title":"European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection.","volume":"5","author":"Riboli","year":"2002","journal-title":"Public Health Nutr"},{"issue":"11","key":"zoi250598r27","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1002\/ijc.30370","article-title":"Worse quality of life in young and recently diagnosed breast cancer survivors compared with female survivors of other cancers: a cross-sectional study.","volume":"139","author":"Li","year":"2016","journal-title":"Int J Cancer"},{"issue":"6","key":"zoi250598r28","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/ije\/dyx085","article-title":"Cohort profile: the Melbourne Collaborative Cohort Study (Health 2020).","volume":"46","author":"Milne","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"4","key":"zoi250598r29","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/oxfordjournals.aje.a010213","article-title":"A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics.","volume":"151","author":"Kolonel","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"6","key":"zoi250598r30","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/cncr.11205","article-title":"Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.","volume":"97","author":"Olsson","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"zoi250598r31","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1186\/bcr3357","article-title":"The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort.","volume":"14","author":"Olson","year":"2012","journal-title":"Breast Cancer Res"},{"issue":"17","key":"zoi250598r32","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/jnci\/90.17.1292","article-title":"Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.","volume":"90","author":"Hankinson","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"zoi250598r33","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1158\/1055-9965.EPI-05-0976","article-title":"The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.","volume":"15","author":"Tworoger","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"zoi250598r34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001492","article-title":"Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.","volume":"10","author":"Pfeiffer","year":"2013","journal-title":"PLoS Med"},{"issue":"21","key":"zoi250598r35","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/jnci\/dji341","article-title":"Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.","volume":"97","author":"Suzuki","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"zoi250598r36","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/jnci\/95.6.448","article-title":"Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.","volume":"95","author":"Dite","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"zoi250598r37","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1038\/bjc.2013.544","article-title":"The association between different night shiftwork factors and breast cancer: a case-control study.","volume":"109","author":"Fritschi","year":"2013","journal-title":"Br J Cancer"},{"issue":"22","key":"zoi250598r38","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1200\/JCO.2010.28.1113","article-title":"Use of bisphosphonates and risk of postmenopausal breast cancer.","volume":"28","author":"Rennert","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"zoi250598r39","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.canep.2013.04.006","article-title":"Shift work, circadian gene variants and risk of breast cancer.","volume":"37","author":"Grundy","year":"2013","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"zoi250598r40","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/ijc.27669","article-title":"Night work and breast cancer: a population-based case-control study in France (the CECILE study).","volume":"132","author":"Menegaux","year":"2013","journal-title":"Int J Cancer"},{"issue":"7","key":"zoi250598r41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002656","article-title":"Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study.","volume":"3","author":"Widschwendter","year":"2008","journal-title":"PLoS One"},{"issue":"8","key":"zoi250598r42","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10654-005-0032-0","article-title":"Factors modifying the association between hormone-replacement therapy and breast cancer risk.","volume":"20","author":"Pesch","year":"2005","journal-title":"Eur J Epidemiol"},{"issue":"8","key":"zoi250598r43","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1023\/A:1008907901087","article-title":"Breastfeeding and breast cancer risk by age 50 among women in Germany.","volume":"11","author":"Chang-Claude","year":"2000","journal-title":"Cancer Causes Control"},{"issue":"1","key":"zoi250598r44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1158\/1055-9965.75.14.1","article-title":"An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in Eastern Finland: three candidate regions found.","volume":"14","author":"Hartikainen","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"zoi250598r45","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3945\/ajcn.2008.26915","article-title":"Dietary patterns and breast cancer risk in Asian American women.","volume":"89","author":"Wu","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"zoi250598r46","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/ijc.23655","article-title":"Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy.","volume":"123","author":"Flesch-Janys","year":"2008","journal-title":"Int J Cancer"},{"key":"zoi250598r47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/1471-2407-10-447","article-title":"An investigation of breast cancer risk factors in Cyprus: a case control study.","volume":"10","author":"Hadjisavvas","year":"2010","journal-title":"BMC Cancer"},{"issue":"3","key":"zoi250598r48","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/ng.318","article-title":"Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.","volume":"41","author":"Zheng","year":"2009","journal-title":"Nat Genet"},{"issue":"1","key":"zoi250598r49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF00694745","article-title":"The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology.","volume":"35","author":"Newman","year":"1995","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"zoi250598r50","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s00439-006-0135-z","article-title":"Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses.","volume":"119","author":"Garc\u00eda-Closas","year":"2006","journal-title":"Hum Genet"},{"issue":"11","key":"zoi250598r51","doi-asserted-by":"publisher","DOI":"10.3310\/pgfar04110","article-title":"Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study.","volume":"4","author":"Evans","year":"2016","journal-title":"Programme Grants for Applied Research"},{"issue":"4","key":"zoi250598r52","doi-asserted-by":"publisher","first-page":"R437","DOI":"10.1186\/bcr811","article-title":"Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study.","volume":"6","author":"Wedr\u00e9n","year":"2004","journal-title":"Breast Cancer Res"},{"issue":"1","key":"zoi250598r53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1079\/PNS200068","article-title":"Energy balance and cancer: the role of sex hormones.","volume":"60","author":"Key","year":"2001","journal-title":"Proc Nutr Soc"},{"issue":"4","key":"zoi250598r54","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12672-013-0145-y","article-title":"Occult breast tumor reservoir: biological properties and clinical significance.","volume":"4","author":"Santen","year":"2013","journal-title":"Horm Cancer"},{"issue":"3","key":"zoi250598r55","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2217\/17455057.4.3.207","article-title":"Does menopausal hormone therapy initiate new breast cancers or promote the growth of existing ones?","volume":"4","author":"Santen","year":"2008","journal-title":"Womens Health (Lond)"},{"issue":"5","key":"zoi250598r56","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1158\/0008-5472.CAN-06-3895","article-title":"Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers.","volume":"67","author":"Gupta","year":"2007","journal-title":"Cancer Res"},{"issue":"4","key":"zoi250598r57","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.maturitas.2004.01.001","article-title":"Pharmacological profile of progestins.","volume":"47","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"issue":"7320","key":"zoi250598r58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature09495","article-title":"RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.","volume":"468","author":"Gonzalez-Suarez","year":"2010","journal-title":"Nature"},{"issue":"3","key":"zoi250598r59","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10654-014-9975-3","article-title":"Serum osteoprotegerin and future risk of cancer and cancer-related mortality in the general population: the Troms\u00f8 study.","volume":"30","author":"Vik","year":"2015","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"zoi250598r60","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12916-017-0786-8","article-title":"Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort.","volume":"15","author":"Fortner","year":"2017","journal-title":"BMC Med"},{"issue":"1","key":"zoi250598r61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/13697137.2017.1388364","article-title":"Cause or prevention of breast cancer with estrogens: analysis from tumor biologic data, growth kinetic model and Women\u2019s Health Initiative study.","volume":"22","author":"Santen","year":"2019","journal-title":"Climacteric"},{"issue":"1","key":"zoi250598r62","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1186\/s12885-023-11049-0","article-title":"Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis.","volume":"23","author":"Mao","year":"2023","journal-title":"BMC Cancer"},{"issue":"16","key":"zoi250598r64","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"issue":"11","key":"zoi250598r65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078016","article-title":"Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France.","volume":"8","author":"Cordina-Duverger","year":"2013","journal-title":"PLoS One"},{"key":"zoi250598r63","doi-asserted-by":"crossref","unstructured":"Hurson? AN, Ahearn? TU, Koka? H, . Risk factors for breast cancer subtypes by race and ethnicity: a scoping review of the literature.? 2024; doi:10.1101\/2024.03.18.24304210","DOI":"10.1101\/2024.03.18.24304210"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2836044\/le_cornet_2025_oi_250598_1751035463.58663.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T15:00:47Z","timestamp":1751900447000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2836044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.19236","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]}}}